Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer

References

• FitzmauriceCAkinyemijuTFAl LamiFHGlobal, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease studyJAMA Oncol20173452454827918777
   PubMed Web of Science ®Google Scholar
• LaurenPThe two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinicalActa Pathol Microbiol Scand196564314914320675
   PubMedGoogle Scholar
• van CutsemESagaertXTopalBHaustermansKPrenenHGastric cancerLancet2016388100602654266427156933
   PubMed Web of Science ®Google Scholar
• HuBEl HajjNSittlerSLammertNBarnesRMeloni-EhrigAGastric cancer: classification, histology and application of molecular pathologyJ Gastrointest Oncol20123325126122943016
   PubMedGoogle Scholar
• AchariAMarshallSEMuirheadHPalmieriRHNoltmannEAGlucose-6-phosphate isomerasePhilos Trans R Soc Lond B Biol Sci198129310631451576115414
   PubMed Web of Science ®Google Scholar
• LiottaLAMandlerRMuranoGTumor cell autocrine motility factorProc Natl Acad Sci U S A19868310330233063085086
   PubMed Web of Science ®Google Scholar
• WatanabeHTakehanaKDateMShinozakiTRazATumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptideCancer Res19965613296029638674049
   PubMed Web of Science ®Google Scholar
• XuJLiuJZhuLZhangXWLiZGZgLSignificance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritisBeijing Da Xue Xue Bao Yi Xue Ban201648694294627987494
   PubMedGoogle Scholar
• FanLYZongMWangQDiagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritisClin Chim Acta201041123–242049205320826128
   PubMed Web of Science ®Google Scholar
• DaiLZhuLJZhengDHElevated serum glucose-6-phosphate isomerase correlates with histological disease activity and clinical improvement after initiation of therapy in patients with rheumatoid arthritisJ Rheumatol201037122452246120810510
   PubMed Web of Science ®Google Scholar
• BaumannMKapplALangTBrandKSiegfriedWPaterokEThe diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancerCancer Invest199083–43513562207761
   PubMed Web of Science ®Google Scholar
• FilellaXMolinaRJoJMasEBallestaAMSerum phosphohexose isomerase activities in patients with colorectal cancerTumour Biol19911263603671798910
   PubMedGoogle Scholar
• DevillersMAhmadLKorri-YoussoufiHSalmonLCarbohydrate-based electrochemical biosensor for detection of a cancer biomarker in human plasmaBiosens Bioelectron20179617818528500945
   PubMed Web of Science ®Google Scholar
• FunasakaTHagaARazANagaseHTumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motilityBiochem Biophys Res Commun2001285111812811437381
   PubMed Web of Science ®Google Scholar
• MurataJLeeHYClairTcDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterasesJ Biol Chem19942694830479304847982964
   PubMed Web of Science ®Google Scholar
• LiYCheQBianYAutocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathwayInt J Oncol20154731017102426201353
   PubMed Web of Science ®Google Scholar
• TsutsumiSYanagawaTShimuraTRegulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signalingJ Biol Chem200327834321653217212783864
   PubMed Web of Science ®Google Scholar
• HagaAFunasakaTNiinakaYRazANagaseHAutocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expressionInt J Cancer2003107570771414566819
   PubMed Web of Science ®Google Scholar
• GongWJiangYWangLExpression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancerClin Cancer Res200511165778578316115916
   PubMed Web of Science ®Google Scholar
• WarburgOThe metabolism of carcinoma cellsJ Cancer Res192591148163
   Google Scholar
• LiSLiZGuoTMaternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancerOncotarget2016756266628026701722
   PubMedGoogle Scholar
• SzászAMLánczkyANagyÁCross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsOncotarget2016731493224933327384994
   PubMedGoogle Scholar
• de PaduaMCDelodiGVučetićMDisrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxiaOncotarget2017850876238763729152106
   PubMedGoogle Scholar
• NiizekiHKobayashiMHoriuchiIHypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cellsBr J Cancer200286121914191912085186
   PubMed Web of Science ®Google Scholar
• FunasakaTYanagawaTHoganVRazARegulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxiaFaseb J200519111422143016126909
   PubMed Web of Science ®Google Scholar
• KhoDHNangia-MakkerPBalanVAutocrine motility factor promotes HER2 cleavage and signaling in breast cancer cellsCancer Res20137341411141923248119
   PubMed Web of Science ®Google Scholar
• JungHSLeeSIKangSHMonoclonal antibodies against autocrine motility factor suppress gastric cancerOncol Lett20171364925493228599497
   PubMed Web of Science ®Google Scholar
• AhmadAAboukameelAKongDPhosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cellsCancer Res20117193400340921389093
   PubMed Web of Science ®Google Scholar
• BayoJFioreEAquinoJBIncreased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinomaPLoS One201494e9517124736611
   PubMed Web of Science ®Google Scholar
• ArakiKShimuraTYajimaTPhosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8J Biol Chem200928447323053231119801670
   PubMed Web of Science ®Google Scholar
• LiYJiaYCheQZhouQWangKWanXPAMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinomaOncotarget2015628263732638726308071
   PubMedGoogle Scholar
• TsutsumiSYanagawaTShimuraTKuwanoHRazAAutocrine motility factor signaling enhances pancreatic cancer metastasisClin Cancer Res200410227775778415570012
   PubMed Web of Science ®Google Scholar
• JiangWGRazADouglas-JonesAManselREExpression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancerJ Histochem Cytochem200654223124116204225
   PubMed Web of Science ®Google Scholar